| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:2750-2756.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Dilated Cardiomyopathy Is Associated With Significant Changes in Collagen Type I/III ratio
From the Medical Clinic II, University Hospital Benjamin Franklin, Freie Universität Berlin, Germany.
Correspondence to Matthias Pauschinger, MD, Medical Clinic II, University Hospital Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany.
Background—It is controversial whether myocardial fibrosis in end-stage dilated cardiomyopathy (DCM) is associated with altered collagen type I/type III (Col I/Col III) ratio.
Methods and Results—Patients with DCM (ejection fraction [EF] <50%, n=12) and with mild global left ventricular dysfunction (EF >50%, n=18) were examined. Col I, Col III, and transforming growth factors-ß1 (TGF-ß1) and -ß2 (TGF-ß2) gene expression in endomyocardial biopsies was evaluated by quantitative competitive reverse transcriptase–polymerase chain reaction (qRT-PCR). Collagen content was quantified after picrosirius red and immunohistological staining and by hydroxyproline assay. In patients with EF <50%, there was a pronounced 2- to 6-fold increase of myocardial Col I mRNA abundance (P<0.01), with a corresponding 1.6-fold increase at the protein level versus that found in patients with EF >50%. The Col III mRNA abundance showed a 2.0-fold increase (P<0.04). There was a relevant shift in the Col I/Col III mRNA ratio for DCM patients (Col I/Col III, 8.2) compared with patients with an EF >50% (Col I/Col III, 6.4). In addition, total collagen content was increased in patients with EF <50% (n=3) (4.3±0.1%) compared with patients with EF >50% (n=8) (2.7±0.9%) (P<0.004). The biochemically determined ratio of hydroxyproline/total protein (n=12) was correlated to the Col I mRNA abundance (P<0.05, r=0.77). TGF-ß1 and TGF-ß2 showed elevated myocardial mRNA abundances (1- to 7-fold and 4- to 5-fold, respectively) in DCM patients.
Conclusions—Differential increase of Col I and Col III leads to an increased Col I/Col III ratio in DCM myocardium. Because Col I provides substantial tensile strength and stiffness, this may contribute to systolic and in particular diastolic dysfunction in DCM.
Key Words: cardiomyopathy • collagen • growth substances • remodeling • polymerase chain reaction
This article has been cited by other articles:
 |
|
 |
|
  B. C. Jensen, P. M. Swigart, T. De Marco, C. Hoopes, and P. C. Simpson {alpha}1-Adrenergic Receptor Subtypes in Nonfailing and Failing Human Myocardium Circ Heart Fail, November 1, 2009; 2(6): 654 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. De Backer The expanding cardiovascular phenotype of Marfan syndrome Eur J Echocardiogr, March 1, 2009; 10(2): 213 - 215. [Full Text] [PDF]
|
|
|
|
 |
|
 A Schumacher, E. Khojeini, and D. Larson ECHO parameters of diastolic dysfunction Perfusion, September 1, 2008; 23(5): 291 - 296. [Abstract] [PDF]
|
|
|
|
 |
|
 A. R. Kompa, F. See, D. A. Lewis, A. Adrahtas, D. M. Cantwell, B. H. Wang, and H. Krum Long-Term but Not Short-Term p38 Mitogen-Activated Protein Kinase Inhibition Improves Cardiac Function and Reduces Cardiac Remodeling Post-Myocardial Infarction J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 741 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Blangy, N. Sadoul, B. Dousset, A. Radauceanu, R. Fay, E. Aliot, and F. Zannad Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction Europace, September 1, 2007; 9(9): 724 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Westermann, S. Van Linthout, S. Dhayat, N. Dhayat, F. Escher, C. Bucker-Gartner, F. Spillmann, M. Noutsias, A. Riad, H.-P. Schultheiss, et al. Cardioprotective and Anti-Inflammatory Effects of Interleukin Converting Enzyme Inhibition in Experimental Diabetic Cardiomyopathy Diabetes, July 1, 2007; 56(7): 1834 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Knosalla, Y.-g. Weng, R. Hammerschmidt, M. Pasic, I. Schmitt-Knosalla, O. Grauhan, M. Dandel, H. B. Lehmkuhl, and R. Hetzer Orthotopic Heart Transplantation in Patients With Marfan Syndrome Ann. Thorac. Surg., May 1, 2007; 83(5): 1691 - 1695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Milting, A. Kassner, L. Arusoglu, H. E. Meyer, M. Morshuis, R. Brendel, B. Klauke, A. El Banayosy, and R. Korfer Influence of ACE-inhibition and mechanical unloading on the regulation of extracellular matrix proteins in the myocardium of heart transplantation candidates bridged by ventricular assist devices Eur J Heart Fail, May 1, 2006; 8(3): 278 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rehal, X. Guo, X. Lu, and G. S. Kassab Duration of no-load state affects opening angle of porcine coronary arteries Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1871 - H1878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Westermann, B. C. Knollmann, P. Steendijk, S. Rutschow, A. Riad, M. Pauschinger, J. D. Potter, H.-P. Schultheiss, and C. Tschope Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy Eur J Heart Fail, March 1, 2006; 8(2): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rutschow, J. Li, H.-P. Schultheiss, and M. Pauschinger Myocardial proteases and matrix remodeling in inflammatory heart disease Cardiovasc Res, February 15, 2006; 69(3): 646 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shigeyama, Y. Yasumura, A. Sakamoto, Y. Ishida, T. Fukutomi, M. Itoh, K. Miyatake, and M. Kitakaze Increased gene expression of collagen Types I and III is inhibited by {beta}-receptor blockade in patients with dilated cardiomyopathy Eur. Heart J., December 2, 2005; 26(24): 2698 - 2705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Satoh, M. Nakamura, T. Akatsu, Y. Shimoda, I. Segawa, and K. Hiramori Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy Eur J Heart Fail, August 1, 2005; 7(5): 755 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yu, R. R. Watson, J. J. Marchalonis, and D. F. Larson A role for T lymphocytes in mediating cardiac diastolic function Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H643 - H651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Klotz, R. F. Foronjy, M. L. Dickstein, A. Gu, I. M. Garrelds, A.H. Jan Danser, M. C. Oz, J. D'Armiento, and D. Burkhoff Mechanical Unloading During Left Ventricular Assist Device Support Increases Left Ventricular Collagen Cross-Linking and Myocardial Stiffness Circulation, July 19, 2005; 112(3): 364 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pauschinger, S. Rutschow, K. Chandrasekharan, D. Westermann, A. Weitz, L. P. Schwimmbeck, H. Zeichhardt, W. Poller, M. Noutsias, J. Li, et al. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis Association with reduced myocardial interleukin-1{beta} and MMP-8 expression and a modulated immune response Eur J Heart Fail, June 1, 2005; 7(4): 444 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohtsuka, K. Inoue, Y. Hara, N. Morioka, K. Ohshima, J. Suzuki, A. Ogimoto, Y. Shigematsu, and J. Higaki Serum markers of angiogenesis and myocardial ultrasonic tissue characterization in patients with dilated cardiomyopathy Eur J Heart Fail, June 1, 2005; 7(4): 689 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Afanasyeva, D. Georgakopoulos, D. F. Belardi, D. Bedja, D. Fairweather, Y. Wang, Z. Kaya, K. L. Gabrielson, E. R. Rodriguez, P. Caturegli, et al. Impaired up-regulation of CD25 on CD4+ T cells in IFN-{gamma} knockout mice is associated with progression of myocarditis to heart failure PNAS, January 4, 2005; 102(1): 180 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. C. Sharma, S. Pokharel, T. J. van Brakel, J. H. van Berlo, J. P.M. Cleutjens, B. Schroen, S. Andre, H. J.G.M. Crijns, H.-J. Gabius, J. Maessen, et al. Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction Circulation, November 9, 2004; 110(19): 3121 - 3128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rosenkranz TGF-{beta}1 and angiotensin networking in cardiac remodeling Cardiovasc Res, August 15, 2004; 63(3): 423 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Knaapen, R. Boellaard, M. J.W. Gotte, P. A. Dijkmans, L. M.C. van Campen, C. C. de Cock, G. Luurtsema, C. A. Visser, A. A. Lammertsma, and F. C. Visser Perfusable Tissue Index as a Potential Marker of Fibrosis in Patients with Idiopathic Dilated Cardiomyopathy J. Nucl. Med., August 1, 2004; 45(8): 1299 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. TSCHOPE, T. WALTHER, J. KONIGER, F. SPILLMANN, D. WESTERMANN, F. ESCHER, M. PAUSCHINGER, J. B. PESQUERO, M. BADER, H.-P. SCHULTHEISS, et al. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene FASEB J, May 1, 2004; 18(7): 828 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Boehmer, V. Wilhelm, M. Palmada, S. Wallisch, G. Henke, H. Brinkmeier, P. Cohen, B. Pieske, and F. Lang Serum and glucocorticoid inducible kinases in the regulation of the cardiac sodium channel SCN5A Cardiovasc Res, March 15, 2003; 57(4): 1079 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pauschinger, K. Chandrasekharan, J. Li, W. Poller, M. Noutsias, C. Tschope, and H.-P. Schultheiss Inflammation and extracellular matrix protein metabolism: two sides of myocardial remodelling Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I49 - I53. [Abstract] [PDF]
|
|
|
|
|
|
M. Noutsias, M. Pauschinger, H.-P. Schultheiss, and U. Kuhl Advances in the immunohistological diagnosis of inflammatory cardiomyopathy Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I54 - I62. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Ahmet, Y. Sawa, K. Iwata, and H. Matsuda Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: A novel gene therapy for cardiomyopathy J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 957 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, P. Lothar Schwimmbeck, C. Tschope, S. Leschka, L. Husmann, S. Rutschow, F. Reichenbach, M. Noutsias, U. Kobalz, W. Poller, et al. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction Cardiovasc Res, November 1, 2002; 56(2): 235 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rosenkranz, M. Flesch, K. Amann, C. Haeuseler, H. Kilter, U. Seeland, K.-D. Schluter, and M. Bohm Alterations of beta -adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta 1 Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1253 - H1262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schwartzkopff, M. Fassbach, B. Pelzer, M. Brehm, and B. E. Strauer Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy Eur J Heart Fail, August 1, 2002; 4(4): 439 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamamoto, T. Masuyama, Y. Sakata, N. Nishikawa, T. Mano, J. Yoshida, T. Miwa, M. Sugawara, Y. Yamaguchi, T. Ookawara, et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart Cardiovasc Res, July 1, 2002; 55(1): 76 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Stawowy, F. Blaschke, P. Pfautsch, S. Goetze, F. Lippek, B. Wollert-Wulf, E. Fleck, and K. Graf Increased myocardial expression of osteopontin in patients with advanced heart failure Eur J Heart Fail, March 1, 2002; 4(2): 139 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J E SANDERSON, K B LAI, I O L SHUM, S WEI, and L T C CHOW Transforming growth factor-beta 1 expression in dilated cardiomyopathy Heart, December 1, 2001; 86(6): 701 - 708. [Full Text] [PDF]
|
|
|
|
|
|
T. W. Hein, S. H. Platts, K. R. Waitkus-Edwards, L. Kuo, S. A. Mousa, and G. A. Meininger Integrin-binding peptides containing RGD produce coronary arteriolar dilation via cyclooxygenase activation Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2378 - H2384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nishikawa, T. Masuyama, K. Yamamoto, Y. Sakata, T. Mano, T. Miwa, M. Sugawara, and M. Hori Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1539 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Zannad, B. Dousset, and F. Alla Treatment of Congestive Heart Failure: Interfering the Aldosterone-Cardiac Extracellular Matrix Relationship Hypertension, November 1, 2001; 38(5): 1227 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Staudt, F. Schaper, V. Stangl, A. Plagemann, M. Bohm, K. Merkel, G. Wallukat, K. D. Wernecke, K. Stangl, G. Baumann, et al. Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin Substitution Circulation, June 5, 2001; 103(22): 2681 - 2686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fielitz, S. Hein, V. Mitrovic, R. Pregla, H. R. Zurbrugg, C. Warnecke, J. Schaper, E. Fleck, and V. Regitz-Zagrosek Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1443 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Sanderson, M. Pauschinger, D. Knopf, S. Petschauer, A. Dorner, W. Poller, P. L. Schwimmbeck, U. Kuhl, and H.-P. Schultheiss Collagen and Transforming Growth Factor-{beta} in Dilated Cardiomyopathy Response Circulation, August 29, 2000; 102 (9): e66 - e66. [Full Text] [PDF]
|
|
|
|
|
|
D. MacKenna, S. R. Summerour, and F. J. Villarreal Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis Cardiovasc Res, May 1, 2000; 46(2): 257 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Starling and P. M. McCarthy Partial left ventriculectomy: sunrise or sunset? Eur J Heart Fail, December 17, 1999; 1(4): 313 - 317. [Abstract] [Full Text] [PDF]
|
|